Detailed Treatment for Diabetic Foot
The treatment of diabetic foot requires a multidisciplinary approach focusing on infection control, wound care, pressure offloading, vascular assessment, and glycemic management to prevent amputation and reduce mortality. 1, 2
Classification and Assessment
Infection Classification
- Mild: Superficial infection limited to skin and subcutaneous tissue
- Moderate: Deeper or more extensive infection
- Severe: Infection with systemic signs or metabolic disturbances 1
Diagnostic Workup
- Obtain deep tissue cultures (not swabs) after wound cleansing and debridement 2
- Plain radiographs for initial screening for osteomyelitis 1
- Consider MRI when osteomyelitis is suspected or soft tissue abscess is present 1
- Probe-to-bone test to help diagnose osteomyelitis 1
- Vascular assessment (ankle pressure, ABI, toe pressure, TcpO2) 1
Treatment Algorithm
1. Infection Management
For Mild Infections:
- Oral antibiotics targeting Staphylococcus aureus and streptococci 1, 2
- Doxycycline 100 mg twice daily
- Clindamycin 300-450 mg three times daily
- For penicillin allergy: Cefalexin 500 mg four times daily
For Moderate to Severe Infections:
- Parenteral broad-spectrum antibiotics 1, 2
- Vancomycin IV + piperacillin-tazobactam IV (covers MRSA, streptococci, gram-negatives, anaerobes)
- Vancomycin IV + imipenem-cilastatin IV
- Consider anti-pseudomonal coverage for patients who have soaked feet, live in warm climates, or have severe infections 2
- Adjust antibiotics based on culture results and clinical response 2
- Continue antibiotics until infection resolves, not through complete healing 2
2. Surgical Management
- Urgent surgical debridement for:
- Sharp debridement of all necrotic tissue and surrounding callus 1
- Consider bone biopsy for definitive diagnosis of osteomyelitis 1
3. Pressure Offloading
For Plantar Ulcers:
- Non-removable knee-high offloading device (first choice) 1
- Total contact cast
- Removable walker rendered irremovable
- When non-removable devices are contraindicated, use removable devices 1
- For non-plantar ulcers: shoe modifications, temporary footwear, toe-spacers, or orthoses 1
- Instruct patients to limit standing/walking and use crutches if necessary 1
4. Vascular Assessment and Management
- For ankle pressure <50 mmHg or ABI <0.5: urgent vascular imaging and revascularization 1
- Consider revascularization when:
- Toe pressure <30 mmHg or TcpO2 <25 mmHg
- Ulcer not showing signs of healing within 6 weeks despite optimal management
- Before considering major amputation 1
- Aim to restore direct flow to at least one foot artery, preferably supplying the wound area 1
5. Local Wound Care
- Frequent inspection and debridement of the ulcer 1
- Select dressings to control excess exudation and maintain moist environment 1
- Consider negative pressure wound therapy for post-operative wounds 1
- Do not use footbaths (causes skin maceration) 1
- Consider hyperbaric oxygen therapy for poorly healing wounds 1
6. Glycemic Control
- Optimize diabetes management to promote healing and prevent recurrence 2
Prevention of Recurrence
Once healed, implement:
- Lifelong observation and professional foot treatment 1
- Appropriate footwear (never return to shoes that caused the ulcer) 1
- Patient education on self-care 1, 2
- Daily foot inspection and washing with careful drying 2
- Applying emollients to dry skin (not between toes) 2
- Avoiding walking barefoot 2
Common Pitfalls to Avoid
- Inadequate sampling for cultures before starting antibiotics 2
- Insufficient debridement of necrotic tissue 2
- Inappropriate antibiotic selection or insufficient duration 2
- Neglecting glycemic control during infection 2
- Treating uninfected wounds with antibiotics 2
- Premature discontinuation of antibiotics, especially with deep infections 2
Monitoring and Follow-up
- Frequent monitoring (every 2-5 days initially) to assess response to therapy 2
- Follow-up for at least 6 months after completion of antibiotic therapy 2
- Regular wound assessment until complete healing 2
Implementing this comprehensive approach can significantly reduce the risk of amputation, which affects up to 80% of diabetic patients with foot ulcers, and decrease the 5-year mortality rate, which is approximately 30% for individuals with diabetic foot ulcers 3.